Page last updated: 2024-08-24

pidotimod and Neoplasms

pidotimod has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benetti, GP; Bombelli, G; Fugazza, L; Illeni, MT; La Vecchia, G; Montalto, F; Stramba Badiale, M; Uslenghi, C1
Auteri, A; Bova, G; Bruni, F; Chiarion, C; Di Renzo, M; Ferrì, P; Girardello, R; Pasqui, AL; Saletti, M1

Trials

1 trial(s) available for pidotimod and Neoplasms

ArticleYear
Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:12A

    Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; CD3 Complex; Double-Blind Method; Female; Humans; Immunity, Cellular; Lymphocyte Count; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Stimulation, Chemical; T-Lymphocytes; Thiazoles; Thiazolidines

1994

Other Studies

1 other study(ies) available for pidotimod and Neoplasms

ArticleYear
The in vitro effect of Pidotimod on some immune functions in cancer patients.
    Immunopharmacology and immunotoxicology, 1997, Volume: 19, Issue:1

    Topics: Adjuvants, Immunologic; Female; Humans; Immunity, Cellular; Immunologic Factors; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines

1997